You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Increased rates of immunosuppressive treatment and hospitalization after checkpoint inhibitor therapy in cancer patients with autoimmune disease

Article info

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Increased rates of immunosuppressive treatment and hospitalization after checkpoint inhibitor therapy in cancer patients with autoimmune disease

Authors

  • David Andrew Bender Department of Radiation Oncology, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Samuel P Heilbroner Department of Radiation Oncology, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Tony J C Wang Department of Radiation Oncology, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center, New York City, New York, USA Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Catherine A Shu Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York City, New York, USA Department of Internal Medicine, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Brigham Hyde Eversana, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Catherine Spina Department of Radiation Oncology, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center, New York City, New York, USA Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Simon K Cheng Department of Radiation Oncology, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center, New York City, New York, USA Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York City, New York, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Simon K Cheng; sc3225{at}cumc.columbia.edu
View Full Text

Citation

Bender DA, Heilbroner SP, Wang TJC, et al
Increased rates of immunosuppressive treatment and hospitalization after checkpoint inhibitor therapy in cancer patients with autoimmune disease
Journal for ImmunoTherapy of Cancer 2020;8:e001627. doi: 10.1136/jitc-2020-001627

Publication history

  • Accepted October 22, 2020
  • First published December 10, 2020.
Online issue publication 
December 10, 2020

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.